Hathal Haddad, Head of Interventional Radiotherapy Unit at University Hospital Tübingen, shared a post on LinkedIn:
“7 Days Until Brachytherapy Awareness Day 2026.
Artificial Intelligence in Interventional Radiotherapy (Brachytherapy)
Artificial Intelligence is transforming the future of cancer care – not by replacing clinicians, but by empowering them to deliver safer, faster, and more personalized treatments.
In Interventional Radiotherapy (Brachytherapy), AI is already improving multiple steps of the clinical workflow, particularly in prostate cancer, from MRI target delineation to CT applicator reconstruction and real-time ultrasound-guided needle placement.
AI is helping us to:
- Automatically contour the prostate and surrounding organs at risk on MRI
- Improve target definition for focal and whole-gland treatments
- Detect and reconstruct needles and sources more accurately on CT
- Support real-time TRUS-guided implantation during procedures
- Reduce treatment planning time
- Improve consistency and reproducibility
- Enhance treatment quality and patient safety
By combining human expertise with artificial intelligence, we can create treatment plans that are more precise, more efficient, and tailored to each individual patient.
However, one principle remains unchanged:
AI supports clinicians – it does not replace them.
The future of brachytherapy lies in the collaboration between radiation oncologists, medical physicists, radiologists, engineers, and intelligent technologies, always with one goal:
Delivering better care for every patient.
Artificial Intelligence empowers clinicians. Brachytherapy saves lives.
17 July 2026 – Brachytherapy Awareness Day.”
Other articles about Radiotherapy on OncoDaily.